Top line accelerating.
+16.4% YoY versus +0.3% prior. 3y CAGR −2.7%.
+16.4%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $7.4B
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Bottom line: RGEN currently has no legendary investor models qualifying — see /stock/RGEN/valuation for the per-model breakdown, but earns a D sector grade (35/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
Concerns — Repligen Corporation's 2.4% ROE is below sector median.
Financial story
Concerns — Repligen Corporation's 2.4% ROE and 0.39 debt-to-equity warrant a closer look at the underlying business.
How does RGEN compare?
Investor verdicts vary by methodology. Full breakdown by investor and signal is in the valuation tab.
RGEN's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
RGEN is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate RGEN a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Repligen Corporation's fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
RGEN trades at 137.2x earnings. Sector context and per-investor signals are in the valuation tab.
+16.4% YoY versus +0.3% prior. 3y CAGR −2.7%.
+16.4%Net margin 6.6% versus −4.0% prior (+10.6pp). Operating 8.1%.
6.6%P/E 135.9x — 1% below the 5y median of 137.6x. Forward 65.9x hints at EPS expansion next year.
135.9xSee exactly where RGEN ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingRGEN sits at #104 in Healthcare with a D grade (35/100).